nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—CYP2A6—lung cancer	0.0104	0.337	CrCbGaD
Nabilone—Dronabinol—ABCG2—lung cancer	0.00926	0.302	CrCbGaD
Nabilone—Dronabinol—CYP1A1—lung cancer	0.00725	0.236	CrCbGaD
Nabilone—Dronabinol—ABCB1—lung cancer	0.00385	0.125	CrCbGaD
Nabilone—CNR1—GPCR ligand binding—APP—lung cancer	0.00102	0.00473	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AVP—lung cancer	0.00102	0.00469	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GRM8—lung cancer	0.00101	0.00465	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GNG11—lung cancer	0.000991	0.00457	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—OXTR—lung cancer	0.000961	0.00443	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GRP—lung cancer	0.000961	0.00443	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CASP3—lung cancer	0.000958	0.00442	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—JUN—lung cancer	0.000931	0.00429	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GRM8—lung cancer	0.000916	0.00423	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GNG11—lung cancer	0.0009	0.00415	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADCY1—lung cancer	0.000891	0.00411	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000886	0.00409	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—POMC—lung cancer	0.000875	0.00404	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL8—lung cancer	0.000862	0.00398	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AXL—lung cancer	0.000839	0.00387	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—SRC—lung cancer	0.000835	0.00385	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—COL4A2—lung cancer	0.000832	0.00384	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GRP—lung cancer	0.00083	0.00383	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—OXTR—lung cancer	0.00083	0.00383	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTHLH—lung cancer	0.000828	0.00382	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GIPR—lung cancer	0.000811	0.00374	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADCY1—lung cancer	0.000809	0.00373	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—STAT3—lung cancer	0.000805	0.00372	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AVP—lung cancer	0.000797	0.00368	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PPP2R1B—lung cancer	0.000788	0.00364	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ANXA1—lung cancer	0.000779	0.00359	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GNG11—lung cancer	0.000777	0.00359	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK3—lung cancer	0.000769	0.00355	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SDC4—lung cancer	0.000757	0.00349	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—OXTR—lung cancer	0.000754	0.00348	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GRP—lung cancer	0.000754	0.00348	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTHLH—lung cancer	0.000752	0.00347	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DUSP3—lung cancer	0.000742	0.00342	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—APP—lung cancer	0.000738	0.00341	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RHEB—lung cancer	0.000727	0.00336	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ANXA1—lung cancer	0.000707	0.00326	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNG11—lung cancer	0.000706	0.00326	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADCY1—lung cancer	0.000699	0.00322	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000696	0.00321	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GRM8—lung cancer	0.000689	0.00318	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000686	0.00316	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL8—lung cancer	0.000677	0.00312	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—POMC—lung cancer	0.000675	0.00311	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—APP—lung cancer	0.00067	0.00309	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SKI—lung cancer	0.000668	0.00308	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—COL4A2—lung cancer	0.000653	0.00301	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTHLH—lung cancer	0.00065	0.003	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GIPR—lung cancer	0.000636	0.00294	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADCY1—lung cancer	0.000635	0.00293	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PPP2R1B—lung cancer	0.000619	0.00285	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ANXA1—lung cancer	0.000611	0.00282	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SDC4—lung cancer	0.000594	0.00274	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTHLH—lung cancer	0.00059	0.00272	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—HRAS—lung cancer	0.000588	0.00271	CbGpPWpGaD
Nabilone—Shock—Paclitaxel—lung cancer	0.000587	0.00078	CcSEcCtD
Nabilone—Dizziness—Vinorelbine—lung cancer	0.000586	0.00078	CcSEcCtD
Nabilone—Orthostatic hypotension—Doxorubicin—lung cancer	0.000586	0.000779	CcSEcCtD
Nabilone—Photosensitivity reaction—Methotrexate—lung cancer	0.000585	0.000777	CcSEcCtD
Nabilone—Tachycardia—Paclitaxel—lung cancer	0.000582	0.000774	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—DUSP3—lung cancer	0.000582	0.00268	CbGpPWpGaD
Nabilone—Anorexia—Etoposide—lung cancer	0.00058	0.000771	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PXN—lung cancer	0.00058	0.00267	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—APP—lung cancer	0.000579	0.00267	CbGpPWpGaD
Nabilone—Body temperature increased—Irinotecan—lung cancer	0.000578	0.000769	CcSEcCtD
Nabilone—Abdominal pain—Irinotecan—lung cancer	0.000578	0.000769	CcSEcCtD
Nabilone—Decreased appetite—Cisplatin—lung cancer	0.000577	0.000767	CcSEcCtD
Nabilone—Hyperhidrosis—Paclitaxel—lung cancer	0.000577	0.000767	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AVP—lung cancer	0.000574	0.00265	CbGpPWpGaD
Nabilone—Anaemia—Docetaxel—lung cancer	0.000572	0.000761	CcSEcCtD
Nabilone—Drowsiness—Methotrexate—lung cancer	0.000571	0.000759	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—RHEB—lung cancer	0.000571	0.00263	CbGpPWpGaD
Nabilone—Depression—Methotrexate—lung cancer	0.00057	0.000757	CcSEcCtD
Nabilone—Anorexia—Paclitaxel—lung cancer	0.000568	0.000756	CcSEcCtD
Nabilone—Hypotension—Etoposide—lung cancer	0.000568	0.000756	CcSEcCtD
Nabilone—Gastritis—Doxorubicin—lung cancer	0.000568	0.000755	CcSEcCtD
Nabilone—Pain—Cisplatin—lung cancer	0.000568	0.000755	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GRP—lung cancer	0.000568	0.00262	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKR1C1—lung cancer	0.000568	0.00262	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—OXTR—lung cancer	0.000568	0.00262	CbGpPWpGaD
Nabilone—Vomiting—Vinorelbine—lung cancer	0.000564	0.00075	CcSEcCtD
Nabilone—Body temperature increased—Gemcitabine—lung cancer	0.000563	0.000749	CcSEcCtD
Nabilone—Rash—Vinorelbine—lung cancer	0.000559	0.000743	CcSEcCtD
Nabilone—Dermatitis—Vinorelbine—lung cancer	0.000559	0.000743	CcSEcCtD
Nabilone—Hypotension—Paclitaxel—lung cancer	0.000557	0.000741	CcSEcCtD
Nabilone—Stomatitis—Methotrexate—lung cancer	0.000557	0.00074	CcSEcCtD
Nabilone—Headache—Vinorelbine—lung cancer	0.000555	0.000738	CcSEcCtD
Nabilone—Syncope—Docetaxel—lung cancer	0.000555	0.000738	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ANXA1—lung cancer	0.000555	0.00256	CbGpPWpGaD
Nabilone—Leukopenia—Docetaxel—lung cancer	0.000554	0.000737	CcSEcCtD
Nabilone—Palpitations—Docetaxel—lung cancer	0.000547	0.000728	CcSEcCtD
Nabilone—Feeling abnormal—Cisplatin—lung cancer	0.000547	0.000727	CcSEcCtD
Nabilone—Paraesthesia—Etoposide—lung cancer	0.000546	0.000726	CcSEcCtD
Nabilone—Loss of consciousness—Docetaxel—lung cancer	0.000544	0.000724	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000543	0.000722	CcSEcCtD
Nabilone—Dyspnoea—Etoposide—lung cancer	0.000542	0.000721	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GRM8—lung cancer	0.000541	0.0025	CbGpPWpGaD
Nabilone—Somnolence—Etoposide—lung cancer	0.000541	0.000719	CcSEcCtD
Nabilone—Cough—Docetaxel—lung cancer	0.00054	0.000719	CcSEcCtD
Nabilone—Insomnia—Paclitaxel—lung cancer	0.000539	0.000717	CcSEcCtD
Nabilone—Epistaxis—Methotrexate—lung cancer	0.000539	0.000716	CcSEcCtD
Nabilone—Hypersensitivity—Irinotecan—lung cancer	0.000539	0.000716	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000538	0.00248	CbGpPWpGaD
Nabilone—Convulsion—Docetaxel—lung cancer	0.000537	0.000713	CcSEcCtD
Nabilone—Paraesthesia—Paclitaxel—lung cancer	0.000535	0.000712	CcSEcCtD
Nabilone—Hypertension—Docetaxel—lung cancer	0.000535	0.000711	CcSEcCtD
Nabilone—Dyspnoea—Paclitaxel—lung cancer	0.000532	0.000707	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GNG11—lung cancer	0.000531	0.00245	CbGpPWpGaD
Nabilone—Somnolence—Paclitaxel—lung cancer	0.00053	0.000705	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—POMC—lung cancer	0.00053	0.00244	CbGpPWpGaD
Nabilone—Decreased appetite—Etoposide—lung cancer	0.000529	0.000703	CcSEcCtD
Nabilone—Arthralgia—Docetaxel—lung cancer	0.000527	0.000701	CcSEcCtD
Nabilone—Chest pain—Docetaxel—lung cancer	0.000527	0.000701	CcSEcCtD
Nabilone—Myalgia—Docetaxel—lung cancer	0.000527	0.000701	CcSEcCtD
Nabilone—Nausea—Vinorelbine—lung cancer	0.000527	0.0007	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—APP—lung cancer	0.000526	0.00243	CbGpPWpGaD
Nabilone—Dyspepsia—Paclitaxel—lung cancer	0.000525	0.000698	CcSEcCtD
Nabilone—Body temperature increased—Cisplatin—lung cancer	0.000525	0.000698	CcSEcCtD
Nabilone—Asthenia—Irinotecan—lung cancer	0.000525	0.000698	CcSEcCtD
Nabilone—Fatigue—Etoposide—lung cancer	0.000524	0.000697	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SKI—lung cancer	0.000524	0.00242	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—lung cancer	0.000522	0.00241	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AVP—lung cancer	0.000521	0.0024	CbGpPWpGaD
Nabilone—Pain—Etoposide—lung cancer	0.00052	0.000692	CcSEcCtD
Nabilone—Constipation—Etoposide—lung cancer	0.00052	0.000692	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—AKT1—lung cancer	0.000519	0.00239	CbGpPWpGaD
Nabilone—Decreased appetite—Paclitaxel—lung cancer	0.000518	0.000689	CcSEcCtD
Nabilone—Dry mouth—Docetaxel—lung cancer	0.000516	0.000686	CcSEcCtD
Nabilone—Fatigue—Paclitaxel—lung cancer	0.000514	0.000684	CcSEcCtD
Nabilone—Pollakiuria—Doxorubicin—lung cancer	0.000512	0.000681	CcSEcCtD
Nabilone—Asthenia—Gemcitabine—lung cancer	0.000511	0.000679	CcSEcCtD
Nabilone—Pain—Paclitaxel—lung cancer	0.00051	0.000678	CcSEcCtD
Nabilone—Constipation—Paclitaxel—lung cancer	0.00051	0.000678	CcSEcCtD
Nabilone—Confusional state—Docetaxel—lung cancer	0.00051	0.000678	CcSEcCtD
Nabilone—Pharyngitis—Methotrexate—lung cancer	0.000509	0.000677	CcSEcCtD
Nabilone—Photosensitivity reaction—Doxorubicin—lung cancer	0.000506	0.000673	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—VEGFC—lung cancer	0.000506	0.00233	CbGpPWpGaD
Nabilone—Pruritus—Gemcitabine—lung cancer	0.000504	0.00067	CcSEcCtD
Nabilone—Infection—Docetaxel—lung cancer	0.000502	0.000668	CcSEcCtD
Nabilone—Feeling abnormal—Etoposide—lung cancer	0.000501	0.000666	CcSEcCtD
Nabilone—Diarrhoea—Irinotecan—lung cancer	0.0005	0.000665	CcSEcCtD
Nabilone—Gastrointestinal pain—Etoposide—lung cancer	0.000497	0.000661	CcSEcCtD
Nabilone—Shock—Docetaxel—lung cancer	0.000497	0.000661	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—lung cancer	0.000495	0.000658	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—lung cancer	0.000494	0.000657	CcSEcCtD
Nabilone—Tachycardia—Docetaxel—lung cancer	0.000493	0.000656	CcSEcCtD
Nabilone—Feeling abnormal—Paclitaxel—lung cancer	0.000491	0.000653	CcSEcCtD
Nabilone—Hypersensitivity—Cisplatin—lung cancer	0.000489	0.00065	CcSEcCtD
Nabilone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000488	0.000648	CcSEcCtD
Nabilone—Diarrhoea—Gemcitabine—lung cancer	0.000487	0.000648	CcSEcCtD
Nabilone—Dizziness—Irinotecan—lung cancer	0.000484	0.000643	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—lung cancer	0.000482	0.000641	CcSEcCtD
Nabilone—Anorexia—Docetaxel—lung cancer	0.000482	0.000641	CcSEcCtD
Nabilone—Abdominal pain—Etoposide—lung cancer	0.000481	0.000639	CcSEcCtD
Nabilone—Body temperature increased—Etoposide—lung cancer	0.000481	0.000639	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—lung cancer	0.000479	0.000637	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—lung cancer	0.000478	0.000636	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADCY1—lung cancer	0.000478	0.0022	CbGpPWpGaD
Nabilone—Asthenia—Cisplatin—lung cancer	0.000476	0.000633	CcSEcCtD
Nabilone—Hypotension—Docetaxel—lung cancer	0.000472	0.000628	CcSEcCtD
Nabilone—Abdominal pain—Paclitaxel—lung cancer	0.000471	0.000627	CcSEcCtD
Nabilone—Body temperature increased—Paclitaxel—lung cancer	0.000471	0.000627	CcSEcCtD
Nabilone—Epistaxis—Doxorubicin—lung cancer	0.000467	0.00062	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PPP2R1B—lung cancer	0.000466	0.00215	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SMARCA4—lung cancer	0.000466	0.00215	CbGpPWpGaD
Nabilone—Vomiting—Irinotecan—lung cancer	0.000465	0.000618	CcSEcCtD
Nabilone—Rash—Irinotecan—lung cancer	0.000461	0.000613	CcSEcCtD
Nabilone—Dermatitis—Irinotecan—lung cancer	0.000461	0.000612	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000461	0.000612	CcSEcCtD
Nabilone—Chills—Methotrexate—lung cancer	0.00046	0.000612	CcSEcCtD
Nabilone—Headache—Irinotecan—lung cancer	0.000458	0.000609	CcSEcCtD
Nabilone—Insomnia—Docetaxel—lung cancer	0.000457	0.000608	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PXN—lung cancer	0.000455	0.0021	CbGpPWpGaD
Nabilone—Diarrhoea—Cisplatin—lung cancer	0.000454	0.000604	CcSEcCtD
Nabilone—Paraesthesia—Docetaxel—lung cancer	0.000454	0.000603	CcSEcCtD
Nabilone—Vomiting—Gemcitabine—lung cancer	0.000453	0.000602	CcSEcCtD
Nabilone—Dyspnoea—Docetaxel—lung cancer	0.000451	0.000599	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AVP—lung cancer	0.00045	0.00208	CbGpPWpGaD
Nabilone—Somnolence—Docetaxel—lung cancer	0.000449	0.000597	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HSPB1—lung cancer	0.000449	0.00207	CbGpPWpGaD
Nabilone—Rash—Gemcitabine—lung cancer	0.000449	0.000597	CcSEcCtD
Nabilone—Dermatitis—Gemcitabine—lung cancer	0.000449	0.000597	CcSEcCtD
Nabilone—Hypersensitivity—Etoposide—lung cancer	0.000448	0.000596	CcSEcCtD
Nabilone—Headache—Gemcitabine—lung cancer	0.000446	0.000593	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AKR1C1—lung cancer	0.000445	0.00206	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—OXTR—lung cancer	0.000445	0.00206	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GRP—lung cancer	0.000445	0.00206	CbGpPWpGaD
Nabilone—Dyspepsia—Docetaxel—lung cancer	0.000445	0.000592	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTHLH—lung cancer	0.000444	0.00205	CbGpPWpGaD
Nabilone—Hypoaesthesia—Doxorubicin—lung cancer	0.000442	0.000587	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—lung cancer	0.000441	0.000586	CcSEcCtD
Nabilone—Decreased appetite—Docetaxel—lung cancer	0.000439	0.000584	CcSEcCtD
Nabilone—Hypersensitivity—Paclitaxel—lung cancer	0.000439	0.000584	CcSEcCtD
Nabilone—Asthenia—Etoposide—lung cancer	0.000436	0.00058	CcSEcCtD
Nabilone—Fatigue—Docetaxel—lung cancer	0.000436	0.000579	CcSEcCtD
Nabilone—Nausea—Irinotecan—lung cancer	0.000434	0.000577	CcSEcCtD
Nabilone—Pain—Docetaxel—lung cancer	0.000432	0.000575	CcSEcCtD
Nabilone—Constipation—Docetaxel—lung cancer	0.000432	0.000575	CcSEcCtD
Nabilone—Back pain—Methotrexate—lung cancer	0.000432	0.000574	CcSEcCtD
Nabilone—Pruritus—Etoposide—lung cancer	0.00043	0.000572	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—lung cancer	0.000428	0.000569	CcSEcCtD
Nabilone—Asthenia—Paclitaxel—lung cancer	0.000428	0.000569	CcSEcCtD
Nabilone—Nausea—Gemcitabine—lung cancer	0.000423	0.000563	CcSEcCtD
Nabilone—Vomiting—Cisplatin—lung cancer	0.000422	0.000561	CcSEcCtD
Nabilone—Pruritus—Paclitaxel—lung cancer	0.000422	0.000561	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—lung cancer	0.000421	0.000559	CcSEcCtD
Nabilone—Rash—Cisplatin—lung cancer	0.000419	0.000557	CcSEcCtD
Nabilone—Dermatitis—Cisplatin—lung cancer	0.000418	0.000556	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ANXA1—lung cancer	0.000418	0.00193	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNG11—lung cancer	0.000417	0.00192	CbGpPWpGaD
Nabilone—Feeling abnormal—Docetaxel—lung cancer	0.000417	0.000554	CcSEcCtD
Nabilone—Diarrhoea—Etoposide—lung cancer	0.000416	0.000553	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—lung cancer	0.000415	0.000552	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—lung cancer	0.000414	0.000551	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—lung cancer	0.000414	0.00055	CcSEcCtD
Nabilone—Gastrointestinal pain—Docetaxel—lung cancer	0.000413	0.00055	CcSEcCtD
Nabilone—Anaemia—Methotrexate—lung cancer	0.000413	0.000549	CcSEcCtD
Nabilone—Flushing—Doxorubicin—lung cancer	0.000412	0.000548	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CXCL8—lung cancer	0.00041	0.00189	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AVP—lung cancer	0.000409	0.00189	CbGpPWpGaD
Nabilone—Diarrhoea—Paclitaxel—lung cancer	0.000408	0.000543	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FLT1—lung cancer	0.000404	0.00187	CbGpPWpGaD
Nabilone—Malaise—Methotrexate—lung cancer	0.000403	0.000535	CcSEcCtD
Nabilone—Dizziness—Etoposide—lung cancer	0.000402	0.000535	CcSEcCtD
Nabilone—Vertigo—Methotrexate—lung cancer	0.000401	0.000533	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—lung cancer	0.000401	0.00185	CbGpPWpGaD
Nabilone—Abdominal pain—Docetaxel—lung cancer	0.0004	0.000531	CcSEcCtD
Nabilone—Body temperature increased—Docetaxel—lung cancer	0.0004	0.000531	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—lung cancer	0.0004	0.000531	CcSEcCtD
Nabilone—Chills—Doxorubicin—lung cancer	0.000398	0.00053	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—VEGFC—lung cancer	0.000397	0.00183	CbGpPWpGaD
Nabilone—Arrhythmia—Doxorubicin—lung cancer	0.000397	0.000527	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NOTCH3—lung cancer	0.000396	0.00183	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APP—lung cancer	0.000396	0.00183	CbGpPWpGaD
Nabilone—Dizziness—Paclitaxel—lung cancer	0.000394	0.000524	CcSEcCtD
Nabilone—Nausea—Cisplatin—lung cancer	0.000394	0.000524	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGF9—lung cancer	0.000393	0.00181	CbGpPWpGaD
Nabilone—Cough—Methotrexate—lung cancer	0.00039	0.000518	CcSEcCtD
Nabilone—Convulsion—Methotrexate—lung cancer	0.000387	0.000514	CcSEcCtD
Nabilone—Vomiting—Etoposide—lung cancer	0.000387	0.000514	CcSEcCtD
Nabilone—Rash—Etoposide—lung cancer	0.000383	0.00051	CcSEcCtD
Nabilone—Dermatitis—Etoposide—lung cancer	0.000383	0.000509	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—POMC—lung cancer	0.000381	0.00176	CbGpPWpGaD
Nabilone—Headache—Etoposide—lung cancer	0.000381	0.000507	CcSEcCtD
Nabilone—Chest pain—Methotrexate—lung cancer	0.00038	0.000505	CcSEcCtD
Nabilone—Myalgia—Methotrexate—lung cancer	0.00038	0.000505	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—lung cancer	0.00038	0.000505	CcSEcCtD
Nabilone—Tension—Doxorubicin—lung cancer	0.000379	0.000504	CcSEcCtD
Nabilone—Vomiting—Paclitaxel—lung cancer	0.000379	0.000504	CcSEcCtD
Nabilone—Rash—Paclitaxel—lung cancer	0.000376	0.0005	CcSEcCtD
Nabilone—Dermatitis—Paclitaxel—lung cancer	0.000376	0.000499	CcSEcCtD
Nabilone—Discomfort—Methotrexate—lung cancer	0.000375	0.000499	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—lung cancer	0.000375	0.000499	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ADCY1—lung cancer	0.000375	0.00173	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUNB—lung cancer	0.000375	0.00173	CbGpPWpGaD
Nabilone—Back pain—Doxorubicin—lung cancer	0.000374	0.000497	CcSEcCtD
Nabilone—Headache—Paclitaxel—lung cancer	0.000374	0.000497	CcSEcCtD
Nabilone—Hypersensitivity—Docetaxel—lung cancer	0.000372	0.000495	CcSEcCtD
Nabilone—Confusional state—Methotrexate—lung cancer	0.000367	0.000488	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PPP2R1B—lung cancer	0.000365	0.00169	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SMARCA4—lung cancer	0.000365	0.00169	CbGpPWpGaD
Nabilone—Vision blurred—Doxorubicin—lung cancer	0.000364	0.000484	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—lung cancer	0.000364	0.00168	CbGpPWpGaD
Nabilone—Asthenia—Docetaxel—lung cancer	0.000363	0.000482	CcSEcCtD
Nabilone—Infection—Methotrexate—lung cancer	0.000362	0.000481	CcSEcCtD
Nabilone—Nausea—Etoposide—lung cancer	0.000361	0.00048	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—lung cancer	0.000359	0.000477	CcSEcCtD
Nabilone—Pruritus—Docetaxel—lung cancer	0.000358	0.000475	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—lung cancer	0.000357	0.000475	CcSEcCtD
Nabilone—Agitation—Doxorubicin—lung cancer	0.000355	0.000472	CcSEcCtD
Nabilone—Nausea—Paclitaxel—lung cancer	0.000354	0.000471	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HSPB1—lung cancer	0.000353	0.00163	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—lung cancer	0.000352	0.00163	CbGpPWpGaD
Nabilone—Hyperhidrosis—Methotrexate—lung cancer	0.000352	0.000468	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTHLH—lung cancer	0.000349	0.00161	CbGpPWpGaD
Nabilone—Malaise—Doxorubicin—lung cancer	0.000349	0.000463	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—lung cancer	0.000347	0.000462	CcSEcCtD
Nabilone—Anorexia—Methotrexate—lung cancer	0.000347	0.000462	CcSEcCtD
Nabilone—Syncope—Doxorubicin—lung cancer	0.000347	0.000461	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—POMC—lung cancer	0.000346	0.0016	CbGpPWpGaD
Nabilone—Leukopenia—Doxorubicin—lung cancer	0.000346	0.00046	CcSEcCtD
Nabilone—Diarrhoea—Docetaxel—lung cancer	0.000346	0.00046	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—lung cancer	0.000342	0.000454	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—STK11—lung cancer	0.00034	0.00157	CbGpPWpGaD
Nabilone—Hypotension—Methotrexate—lung cancer	0.00034	0.000453	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—lung cancer	0.00034	0.000452	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL6R—lung cancer	0.000338	0.00156	CbGpPWpGaD
Nabilone—Cough—Doxorubicin—lung cancer	0.000337	0.000448	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—lung cancer	0.000335	0.000445	CcSEcCtD
Nabilone—Dizziness—Docetaxel—lung cancer	0.000334	0.000444	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—lung cancer	0.000334	0.000444	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000332	0.000441	CcSEcCtD
Nabilone—Insomnia—Methotrexate—lung cancer	0.00033	0.000438	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—lung cancer	0.000329	0.000438	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—lung cancer	0.000329	0.000438	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—lung cancer	0.000329	0.000438	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FOXO3—lung cancer	0.000329	0.00152	CbGpPWpGaD
Nabilone—Anxiety—Doxorubicin—lung cancer	0.000328	0.000436	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ANXA1—lung cancer	0.000328	0.00151	CbGpPWpGaD
Nabilone—Paraesthesia—Methotrexate—lung cancer	0.000327	0.000435	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—lung cancer	0.000325	0.000432	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—lung cancer	0.000325	0.000432	CcSEcCtD
Nabilone—Somnolence—Methotrexate—lung cancer	0.000324	0.000431	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MAP2K1—lung cancer	0.000322	0.00149	CbGpPWpGaD
Nabilone—Dry mouth—Doxorubicin—lung cancer	0.000322	0.000428	CcSEcCtD
Nabilone—Vomiting—Docetaxel—lung cancer	0.000321	0.000427	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—lung cancer	0.000321	0.000426	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—lung cancer	0.00032	0.00148	CbGpPWpGaD
Nabilone—Rash—Docetaxel—lung cancer	0.000319	0.000424	CcSEcCtD
Nabilone—Dermatitis—Docetaxel—lung cancer	0.000318	0.000423	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—lung cancer	0.000318	0.000423	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FLT1—lung cancer	0.000317	0.00146	CbGpPWpGaD
Nabilone—Decreased appetite—Methotrexate—lung cancer	0.000317	0.000421	CcSEcCtD
Nabilone—Headache—Docetaxel—lung cancer	0.000317	0.000421	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—lung cancer	0.000314	0.00145	CbGpPWpGaD
Nabilone—Fatigue—Methotrexate—lung cancer	0.000314	0.000418	CcSEcCtD
Nabilone—Infection—Doxorubicin—lung cancer	0.000313	0.000417	CcSEcCtD
Nabilone—Pain—Methotrexate—lung cancer	0.000312	0.000414	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—APP—lung cancer	0.000311	0.00143	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH3—lung cancer	0.000311	0.00143	CbGpPWpGaD
Nabilone—Shock—Doxorubicin—lung cancer	0.00031	0.000413	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGF9—lung cancer	0.000308	0.00142	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AVP—lung cancer	0.000308	0.00142	CbGpPWpGaD
Nabilone—Tachycardia—Doxorubicin—lung cancer	0.000308	0.000409	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—lung cancer	0.000307	0.00142	CbGpPWpGaD
Nabilone—Hyperhidrosis—Doxorubicin—lung cancer	0.000305	0.000405	CcSEcCtD
Nabilone—Anorexia—Doxorubicin—lung cancer	0.000301	0.0004	CcSEcCtD
Nabilone—Nausea—Docetaxel—lung cancer	0.0003	0.000399	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—lung cancer	0.0003	0.000399	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—POMC—lung cancer	0.000299	0.00138	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Methotrexate—lung cancer	0.000298	0.000396	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IGF1R—lung cancer	0.000296	0.00137	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—lung cancer	0.000295	0.00136	CbGpPWpGaD
Nabilone—Hypotension—Doxorubicin—lung cancer	0.000295	0.000392	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—JUNB—lung cancer	0.000294	0.00136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HES1—lung cancer	0.000291	0.00134	CbGpPWpGaD
Nabilone—Body temperature increased—Methotrexate—lung cancer	0.000288	0.000383	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—lung cancer	0.000288	0.000383	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000287	0.000382	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—RAF1—lung cancer	0.000286	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—lung cancer	0.000286	0.00132	CbGpPWpGaD
Nabilone—Insomnia—Doxorubicin—lung cancer	0.000285	0.000379	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—lung cancer	0.000283	0.000377	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—IL2—lung cancer	0.000282	0.0013	CbGpPWpGaD
Nabilone—Dyspnoea—Doxorubicin—lung cancer	0.000281	0.000374	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—lung cancer	0.00028	0.000373	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—lung cancer	0.000279	0.00129	CbGpPWpGaD
Nabilone—Dyspepsia—Doxorubicin—lung cancer	0.000278	0.000369	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—lung cancer	0.000276	0.00128	CbGpPWpGaD
Nabilone—CNR1—mammary gland—lung cancer	0.000276	0.627	CbGeAlD
Nabilone—Decreased appetite—Doxorubicin—lung cancer	0.000274	0.000365	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—lung cancer	0.000272	0.000362	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—POMC—lung cancer	0.000272	0.00125	CbGpPWpGaD
Nabilone—Constipation—Doxorubicin—lung cancer	0.00027	0.000359	CcSEcCtD
Nabilone—Pain—Doxorubicin—lung cancer	0.00027	0.000359	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—lung cancer	0.000268	0.000357	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CXCL8—lung cancer	0.000268	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STK11—lung cancer	0.000267	0.00123	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB3—lung cancer	0.000266	0.00123	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6R—lung cancer	0.000265	0.00122	CbGpPWpGaD
Nabilone—Asthenia—Methotrexate—lung cancer	0.000261	0.000348	CcSEcCtD
Nabilone—Feeling abnormal—Doxorubicin—lung cancer	0.00026	0.000346	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—lung cancer	0.000258	0.000343	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FOXO3—lung cancer	0.000258	0.00119	CbGpPWpGaD
Nabilone—Pruritus—Methotrexate—lung cancer	0.000258	0.000343	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL2—lung cancer	0.000256	0.00118	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TERT—lung cancer	0.000255	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAP2K1—lung cancer	0.000253	0.00117	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—lung cancer	0.000251	0.00116	CbGpPWpGaD
Nabilone—Abdominal pain—Doxorubicin—lung cancer	0.000249	0.000332	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—lung cancer	0.000249	0.000332	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—lung cancer	0.000249	0.000331	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGFR1—lung cancer	0.000248	0.00114	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—lung cancer	0.000244	0.00113	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AVP—lung cancer	0.000242	0.00111	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—lung cancer	0.000241	0.00111	CbGpPWpGaD
Nabilone—Dizziness—Methotrexate—lung cancer	0.000241	0.00032	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—APOA1—lung cancer	0.000235	0.00109	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KDR—lung cancer	0.000233	0.00108	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1R—lung cancer	0.000233	0.00107	CbGpPWpGaD
Nabilone—Hypersensitivity—Doxorubicin—lung cancer	0.000232	0.000309	CcSEcCtD
Nabilone—Vomiting—Methotrexate—lung cancer	0.000232	0.000308	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—lung cancer	0.000232	0.00107	CbGpPWpGaD
Nabilone—Rash—Methotrexate—lung cancer	0.00023	0.000305	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—lung cancer	0.000229	0.000305	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HES1—lung cancer	0.000228	0.00105	CbGpPWpGaD
Nabilone—Headache—Methotrexate—lung cancer	0.000228	0.000303	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—lung cancer	0.000226	0.000301	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—RAF1—lung cancer	0.000224	0.00103	CbGpPWpGaD
Nabilone—Pruritus—Doxorubicin—lung cancer	0.000223	0.000297	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—IL2—lung cancer	0.000221	0.00102	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—lung cancer	0.000219	0.00101	CbGpPWpGaD
Nabilone—Nausea—Methotrexate—lung cancer	0.000216	0.000288	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—lung cancer	0.000216	0.000287	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—APC—lung cancer	0.000215	0.000992	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—lung cancer	0.000215	0.000992	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KIT—lung cancer	0.000215	0.000992	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—NRAS—lung cancer	0.000215	0.000992	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGF—lung cancer	0.000212	0.00098	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—lung cancer	0.00021	0.00097	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB3—lung cancer	0.000209	0.000964	CbGpPWpGaD
Nabilone—Dizziness—Doxorubicin—lung cancer	0.000209	0.000277	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MAPK3—lung cancer	0.000206	0.00095	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—POMC—lung cancer	0.000205	0.000944	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—BRAF—lung cancer	0.000202	0.000932	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL2—lung cancer	0.000201	0.000927	CbGpPWpGaD
Nabilone—Vomiting—Doxorubicin—lung cancer	0.000201	0.000267	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TERT—lung cancer	0.0002	0.000924	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6R—lung cancer	0.0002	0.000921	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CREBBP—lung cancer	0.000199	0.00092	CbGpPWpGaD
Nabilone—Rash—Doxorubicin—lung cancer	0.000199	0.000264	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—lung cancer	0.000199	0.000264	CcSEcCtD
Nabilone—Headache—Doxorubicin—lung cancer	0.000198	0.000263	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—EGFR—lung cancer	0.000196	0.000904	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR1—lung cancer	0.000194	0.000897	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIF1A—lung cancer	0.000191	0.000883	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAP2K1—lung cancer	0.00019	0.000878	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CD—lung cancer	0.000189	0.000872	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—lung cancer	0.000187	0.000249	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—lung cancer	0.000187	0.000864	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—lung cancer	0.000185	0.000854	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA1—lung cancer	0.000185	0.000852	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KDR—lung cancer	0.000183	0.000845	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—lung cancer	0.00017	0.000784	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MDM2—lung cancer	0.000169	0.000781	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAF1—lung cancer	0.000169	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KIT—lung cancer	0.000169	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—lung cancer	0.000169	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—lung cancer	0.000169	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—NRAS—lung cancer	0.000169	0.000778	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—lung cancer	0.000167	0.00077	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGF—lung cancer	0.000167	0.000769	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—lung cancer	0.000165	0.00076	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MTOR—lung cancer	0.000165	0.00076	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK3—lung cancer	0.000162	0.000745	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—POMC—lung cancer	0.000161	0.000741	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—BRAF—lung cancer	0.000159	0.000732	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—lung cancer	0.000158	0.00073	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRAS—lung cancer	0.000157	0.000726	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6R—lung cancer	0.000157	0.000723	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CREBBP—lung cancer	0.000156	0.000722	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—lung cancer	0.000154	0.000709	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—lung cancer	0.000153	0.000706	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—lung cancer	0.000151	0.000699	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL2—lung cancer	0.000151	0.000698	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—lung cancer	0.000151	0.000694	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAP2K1—lung cancer	0.000149	0.000689	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CD—lung cancer	0.000148	0.000684	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—lung cancer	0.000147	0.00068	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUN—lung cancer	0.000147	0.000679	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—lung cancer	0.000147	0.000678	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—lung cancer	0.000145	0.00067	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—lung cancer	0.000143	0.000661	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1A—lung cancer	0.000143	0.000658	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—lung cancer	0.000142	0.000657	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—lung cancer	0.000139	0.000641	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EP300—lung cancer	0.000136	0.000626	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—lung cancer	0.000133	0.000615	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MDM2—lung cancer	0.000133	0.000613	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAF1—lung cancer	0.000132	0.000611	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—lung cancer	0.000132	0.000609	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—lung cancer	0.000131	0.000604	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTOR—lung cancer	0.000129	0.000596	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—lung cancer	0.000129	0.000596	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—lung cancer	0.000129	0.000593	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—lung cancer	0.000127	0.000587	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRAS—lung cancer	0.000127	0.000586	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—lung cancer	0.000124	0.000573	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRAS—lung cancer	0.000123	0.000569	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK3—lung cancer	0.000122	0.000561	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—lung cancer	0.00012	0.000554	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—lung cancer	0.000119	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL2—lung cancer	0.000119	0.000548	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—lung cancer	0.000118	0.000546	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—lung cancer	0.000118	0.000545	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—lung cancer	0.000116	0.000534	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—lung cancer	0.000116	0.000534	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUN—lung cancer	0.000115	0.000533	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—lung cancer	0.000112	0.000518	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1A—lung cancer	0.000112	0.000516	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—lung cancer	0.000112	0.000515	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—lung cancer	0.000109	0.000504	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—lung cancer	0.000109	0.000503	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EP300—lung cancer	0.000107	0.000491	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SRC—lung cancer	0.000104	0.000478	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—lung cancer	0.000101	0.000465	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—lung cancer	0.0001	0.000463	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—lung cancer	9.99e-05	0.000461	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRAS—lung cancer	9.96e-05	0.00046	CbGpPWpGaD
Nabilone—CNR1—lung—lung cancer	9.76e-05	0.222	CbGeAlD
Nabilone—CNR2—Signaling Pathways—TP53—lung cancer	9.71e-05	0.000448	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—lung cancer	9.54e-05	0.00044	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRAS—lung cancer	9.29e-05	0.000429	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—lung cancer	9.28e-05	0.000428	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—lung cancer	9.08e-05	0.000419	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—lung cancer	8.89e-05	0.00041	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—lung cancer	8.58e-05	0.000396	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—lung cancer	8.2e-05	0.000378	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—lung cancer	7.88e-05	0.000364	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—lung cancer	7.62e-05	0.000352	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—lung cancer	7.29e-05	0.000336	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—lung cancer	6.98e-05	0.000322	CbGpPWpGaD
Nabilone—CNR1—lymph node—lung cancer	6.67e-05	0.152	CbGeAlD
Nabilone—CNR1—Signaling Pathways—AKT1—lung cancer	6.44e-05	0.000297	CbGpPWpGaD
